Results 201 to 210 of about 62,998 (285)

Genomic Surveillance of <i>Plasmodium falciparum</i> Drug Resistance Markers Between October 2021 and June 2023 in Kigali, Rwanda. [PDF]

Pathogens
Fankem SN, Mbonimpa JB, Kalimba EM, Diallo MT, Teke ME, Souopgui J.   +5 more
europepmc   +1 more source

Safety of Artemisinin Antimalarials [PDF]

Clinical Infectious Diseases, 2006
openaire   +2 more sources

Eschweilenol C and subfractions from Terminalia plants disrupt haemoglobin metabolism, inhibiting Plasmodium falciparum growth at rings and trophozoite stages. [PDF]

Malar J
Tali MBT, Mbouna CDJ, Zehra A, Wouamba SCN, Mouthe GPK, Kamche AY, Dize D, Kouam SF, Kamdem BP, Tchouankeu JC, Khan F, Boyom FF.   +11 more
europepmc   +1 more source

Synthetic Derivatives of Artemisinin and Cancer.

, 2016
Amit Sarder, Yuba Raj Pokharel
openalex   +2 more sources

Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine. [PDF]

Malar J
Mombo-Ngoma G, Ramharter M, Zoleko Manego R, Lell B, Bassat Q, Aide P, Maiga Ascofare O, Wells TNC, Djimde A, Ntoumi F, Kremsner PG.   +10 more
europepmc   +1 more source

Assessing the Anti-Cryptococcus Antifungal Potential of Artemisinin. [PDF]

Int J Mol Sci
Maliehe M, Albertyn J, Sebolai OM.
europepmc   +1 more source

Antifungal Mechanism Effect of Artemisinin on <i>Fusarium solani</i>. [PDF]

Pharmaceuticals (Basel)
Espinoza C, Quiroz-Figueroa FR, Guzmán-López O, Ruiz-May E, Gallegos-García V, Salinas-Castro A, García-Serrano G, Meza-Menchaca T.   +7 more
europepmc   +1 more source

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam

, 2012
Nguyễn Xuân Thành, Trieu Nguyen Trung, Nguyen Chinh Phong, Huynh Hong Quang, Bui Dai, G. Dennis Shanks, Marina Chavchich, Michael D. Edstein   +7 more
openalex   +1 more source

Liver-Microbiome Crosstalk Mediates the Protective Effects of Artemisinin in Clostridium perfringens Models. [PDF]

Microb Biotechnol
Han H, Li Y, Wang L, Jin Z, Zhou W, Zhang B, Jia C, Zhang W, Wang Y, Qiu L, Bing S, Wang S, Ren Z.   +12 more
europepmc   +1 more source

Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda: a promising approach for managing therapies in malaria-endemic countries. [PDF]

BMJ Glob Health
Muvunyi CM, Gashema P, Mbituyumuremyi A, Iradukunda PG, Siddig EE, Niyonzima JD, Hakizimana E, Umulisa N, Noor AM, Mugabo Semahore J, Tuyishime A, Harelimana JD, Umuhire J, Butera Y, Nsanzimana S.   +14 more
europepmc   +1 more source